The rise in the number of start-ups driving innovation is one of the main factors anticipated to fuel the growth of the continuous positive airway pressure (CPAP) market during the forecast period. The continuous positive airway pressure (CPAP) industry is expected to develop due to the rising prevalence of obstructive sleep apnea. Moreover, it is predicted that the market for continuous positive airway pressure (CPAP) will expand more slowly due to the increased prevalence of respiratory disorders among the senior population. On the other hand, the market for continuous positive airway pressure (CPAP) is expected to see growth challenges during the timeline due to the increased device costs.
COVID-19 IMPACT
This pandemic's rise has significantly negatively influenced the world economy, leading to instability in the environment and supply chain. The lack of ventilators has forced medical professionals to explore alternatives to provide respiratory therapy to COVID-19 patients, which has accelerated the introduction of CPAP equipment. Aerosolization has been minimized by the necessary adjustments to convert PAP devices to treat respiratory insufficiency. These elements significantly contribute to the market's successful development of airway pressure devices. ResMed recently announced initiatives to increase access to respiratory support devices for COVID-19 patients.
DRIVING FACTORS
Increasing Government Initiatives and Growing Global Sleep Apnea Burden to Promote Market Growth
Continuous positive airway pressure (CPAP) device demand has been rising steadily globally, providing market participants with a promising growth outlook throughout the forecast period. Heart conditions, obesity, diabetes, and depression are just a few health issues brought on by sleep apnea. Conversely, sleep apnea that is not treated might result in work-related accidents and decreased productivity. Over 350 million people experience sleep apnea worldwide, according to the Centers for Disease Control and Prevention (CDC). The introduction of continuous positive airway pressure devices is consequently driven by rising awareness of sleep apnea and related concomitant diseases. Additionally, governments throughout the world are developing several programs to raise awareness of obstructive sleep apnea in an effort to combat its rising incidence, which is further boosting the market growth.
RESTRAINING FACTORS
The Expansion Of The Market Is Constrained By The High Cost Of CPAP Equipment
The price of a CPAP machine, a humidifier, a heated hose, a face mask or nasal mask, and a filter together makes up the total upfront cost of setting up a CPAP machine for a new patient. According to the brand, technology, and features of the equipment, the average cost of a CPAP machine, for instance, ranges from USD 250 to over USD 1,000. It is necessary to replace the CPAP machine every five years. The cost of treatment rises if the patient requires routine replacements of the heated tube, humidifier chamber, reusable filter, CPAP mask, cushion, and mask every 3 to 4 weeks or every 3 to 4 months.
SEGMENTATION
By Product
%20Devices%20Market%20By%20Type.jpg)
Based on the product, the continuous positive airway pressure (CPAP) devices market is segmented into CPAP devices, CPAP humidifiers, CPAP masks, full face masks, nasal pillow masks, nasal masks and accessories. The CPAP devices category dominated the market in 2022 because more doctors are prescribing CPAP machines as the first line of treatment for individuals with sleep apnea. The segment is also significantly influenced by the low cost of the gadgets and technological improvements, which promote end-user adoption. For instance, InnAccel introduced the first portable neonatal CPAP device in the world in January 2019 to support severely ill infants with respiratory distress syndrome (RDS). The device addresses the nearly 160,000 premature infant deaths in India yearly by respiratory illnesses.
By Application
Based on application, the continuous positive airway pressure (CPAP) devices market is segmented into obstructive sleep apnea, respiratory failures and others. The obstructive sleep apnea category dominated the market in 2022. The widespread usage of CPAP machines to treat Sleep Apnea and stop snoring is responsible for this dominance. Such patients' doctors might advise utilizing a CPAP machine. The market is expected to experience a growth in demand due to the rising prevalence of various health issues, creating profitable chances for the top players to expand their production and distribution capabilities to meet the soaring needs worldwide. Nearly 30 million adults in the United States, according to research by the American Academy of Sleep Medicine, have obstructive sleep apnea. This chronic condition causes the upper airway to repeatedly collapse while you sleep and is thought to affect 40% to 60% of people with cardiovascular disease.
By End User
Based on end users, the continuous positive airway pressure (CPAP) devices market is segmented into hospitals, clinics, sleep centers and home care settings. The hospital category dominated the market in 2022 because there are more private hospitals, and the reimbursement policies are good. With 7 to 8 beds in each lab, there were over 4,700 sleep centers in the United States in 2017. On the other hand, the home care setting category is anticipated to have a significant increase due to rising demand for CPAP equipment for home use.
REGIONAL INSIGHTS
%20Devices%20Market%20By%20Region.jpg)
North America is projected to hold the largest share of the continuous positive airway pressure (CPAP) devices market over the forecast period. Strong healthcare infrastructure and major healthcare businesses investing in R&D operations to address the rising prevalence of sleep apnea support the region. According to the American Sleep Association, 50 to 70 million Americans experience various sleep disorders yearly. On the other hand, the Asia Pacific continuous positive airway pressure (CPAP) devices market is anticipated to grow significantly due to the soaring demand for technologically superior CPAP equipment in nations like South Korea and India, as well as the quickly expanding healthcare infrastructure, spending, and R&D activities. Rapid technological improvements, a growing geriatric population, and rising respiratory illnesses like chronic obstructive pulmonary disease (COPD), TB, asthma, and sleep apnea drive market growth.
LIST OF KEY COMPANIES PROFILED:
- Medtronic Plc.
- Smiths Group plc.
- Koninklijke Philips N.V.
- Dragerwerk AG & Co.KGaA
- Fisher & Paykel Healthcare
- Hamilton Medical AG & Co.KGaA
- Fisher & Paykel Healthcare
- Hamilton Medical AG
- ResMed Inc.
- Devilbiss Healthcare LLC
- 3B Medical,Inc
- BMC Medical Co.Ltd
Recent Development:
- April 2019: With a newly created nasal cradle cushion that fits under the user's nose, ResMed introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S.
| Attributes | Details |
| Market Size in 2022 | USD 5.2 Billion |
| Market Forecast in 2030 | USD 7.8 Billion |
| Compound Annual Growth Rate | 5.90% |
| Unit | Revenue (USD Million) and Volume (Kilo Tons) |
| Segmentation | By Product, By Application, By End User and By Geography |
| By Product |
|
| By Application |
|
| By End User |
|
| By Region |
|
| Base Year | 2022 |
| Historical Year | 2016-2021 |
| Forecast Year | 2023-2030 |
